Study close out for the randomized trial to evaluate the virologic response and pharmacokinetics of 2 potent regimens in HIV infected women initiating triple antiretroviral regimens between 20 & 36…
Ended Awarded Last action
- Contract number
- 75N94020F00001
- Awardee
-
Westat, Inc. UEI NVUWAFWQ57S5
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $354,670
Award facts
- Opportunity
-
- NIHNICHDMPIDB20181 Solicitation number
- NICHD International and Domestic Pediatric and Maternal HIV Studies and Other Infectious Diseases Coordinating Center Award Notice · Posted Jan 13, 2017
- Contract value 100% obligated
- $354,670.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$2,314 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $52,284 | |
| Other Administrative Action | $0 | |
| Original award | $304,700 |
About this award
This is a Cost Plus Fixed Fee delivery order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Westat, Inc., a for-profit professional services firm. The contract is for a study closeout of a randomized trial evaluating the virologic response and pharmacokinetics of two antiretroviral regimens in HIV-infected pregnant women. The contract has a ceiling value of $354,670.38 and a completion date of June 30, 2022. This work falls under NICHD's major program for international and domestic pediatric and maternal HIV and other highly infectious diseases. The contract does not have a set-aside designation.
Description
Study close out for the randomized trial to evaluate the virologic response and pharmacokinetics of 2 potent regimens in HIV infected women initiating triple antiretroviral regimens between 20 & 36 weeks of pregnancy
Quick answers
Who was awarded contract 75N94020F00001?
75N94020F00001 was awarded to Westat, Inc. by National Institute of Child Health and Human Development (National Institutes of Health) on December 1, 2019.
How much is contract 75N94020F00001 worth?
The government has obligated $354,670 on 75N94020F00001.
Is contract 75N94020F00001 an order under another contract?
Yes. 75N94020F00001 is a delivery order under HHSN275201800001I, an indefinite delivery contract.
Was contract 75N94020F00001 competed?
The extent of competition for 75N94020F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award